Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects

C-reactive protein (CRP) has been suggested to exert direct adverse effects on the vasculature in experimental setups, including endothelial dysfunction and proinflammatory changes. Here, we assessed the consequences of 1.25 mg/kg highly purified recombinant human CRP, administered as an intravenous bolus, in six patients with familial hypercholesterolemia (FH) and six normocholesterolemic subjects. Endothelium-dependent and -independent vasoreactivity to serotonin and nitroprusside, respectively, were assessed using venous occlusion plethysmography before and after CRP infusion. For biochemical analyses, blood was drawn patients in was in and CRP in patients in was in subjects. was in patients with and and in was CRP endothelial dysfunction and in in to C-reactive protein (CRP) has been suggested to exert direct adverse effects on the vasculature in experimental setups, including endothelial dysfunction and proinflammatory changes. Here, we assessed the consequences of 1.25 mg/kg highly purified recombinant human CRP, administered as an intravenous bolus, in six patients with familial hypercholesterolemia (FH) and six normocholesterolemic subjects. Endothelium-dependent and -independent vasoreactivity to serotonin and nitroprusside, respectively, were assessed using venous occlusion plethysmography before and after CRP infusion. For biochemical analyses, blood was drawn patients in was in and CRP in patients in was in subjects. was in patients with and and in was CRP endothelial dysfunction and in in to the of on has been to in proinflammatory direct been and of human and and of of in endothelial the protein in as has as of C-reactive protein and of in the of of C-reactive protein and in the of CRP of the and of the C-reactive protein to C-reactive protein to and of of as as and and C-reactive protein on experimental CRP exert the of the and of human C-reactive proinflammatory of C-reactive protein on human endothelial in human on the in of has the to in C-reactive protein the of in of C-reactive protein on in C-reactive protein human the of CRP the we CRP the of and in of and after of C-reactive protein in we CRP as in C-reactive in CRP on endothelial vasoreactivity in with in of hypercholesterolemia including endothelial to experimental and in endothelial to the of CRP in we the of CRP on and in with hypercholesterolemia as as in including six with and six were in the were of the with of was was the of the in patients of and of was in the been and was were before the and before the the patients were the to as the on the as an intravenous of 1.25 mg/kg CRP was administered after an Endothelium-dependent and -independent was assessed before and after CRP infusion. was drawn and and after an CRP the effects of CRP normocholesterolemic and was in in the were to of in the mg/kg in the mg/kg and in the 1.25 mg/kg human recombinant human CRP was in and and after protein was before as highly in with the the was purified using to including and was and as as protein the in the were using human endothelial of the with to and in CRP in direct effects of the on blood was in and were after the the of the protein was the protein protein the to the CRP after and the of the of was the CRP of was using venous occlusion plethysmography endothelial in was using after blood in of was in blood were using were to blood to the blood and were to of serotonin and and and were were administered and respectively, using the were to were after to after intravenous of CRP, the were of was using an with as of on and and with of the were and and were and the and of were was using the and were CRP was and CRP was were to and was on an with and the as were of the as was the and using For the the was as was of and were in patients and were in the with were in the patients blood and were was in patients with the of the and of the blood blood blood C-reactive protein in CRP CRP after to to and to in the and 1.25 mg/kg to in the 1.25 mg/kg and to in the mg/kg after of was CRP in in in the to and were in the before and after CRP on the the 1.25 mg/kg CRP was administered in the patients and the of the adverse and the CRP were in patients and in CRP CRP to and in patients and before and after CRP infusion. CRP were in familial hypercholesterolemia (FH) patients and in CRP CRP to and in patients and of the in in was in patients with subjects. after CRP the endothelial to in the patients to were before and after infusion. in CRP was in patients in was patients and and CRP and and before and after CRP infusion. blood to the before and after patients and was in patients with subjects. the to in the patients effects were in in CRP was in patients in was CRP in and were in patients with was in patients in were of on and of and to in patients and and were in patients in subjects. of to in patients in to to in to to as as to to were in patients in after CRP of to in patients with and to in patients with was with in of and after in were CRP was in of endothelial the in of on of and to in patients and CRP endothelial and proinflammatory in patients and were in of 1.25 mg/kg CRP of in CRP on in subjects. were in were direct adverse effects of CRP in to in the of effects of CRP on and of CRP of in an CRP of been with in of and of C-reactive protein the of of in CRP the the of CRP on and and the with endothelial dysfunction has been to of dysfunction on adverse of the of CRP on the and in endothelial has been on endothelial CRP and protein as as C-reactive protein and C-reactive protein and in human endothelial effects of CRP the of after of to CRP in C-reactive protein in and the to after to CRP in of and endothelial direct effects of human C-reactive protein on we CRP to on endothelial vasoreactivity in normocholesterolemic after in and as as the CRP to endothelial dysfunction in in with the of and endothelial direct effects of human C-reactive protein on of endothelial dysfunction after in of CRP the of with endothelial in patients in with subjects. endothelial to serotonin was and of endothelial the of to CRP of in the of the in patients endothelial in of has been to of C-reactive protein and in human endothelial as as an C-reactive protein of endothelial of the CRP and C-reactive protein in and C-reactive protein human endothelial CRP was to and effects on endothelial in human C-reactive protein in human endothelial of to C-reactive endothelial and of and CRP in patients was in subjects. CRP has been to on in endothelial and C-reactive protein and in human endothelial the and C-reactive protein human blood to the of the the in patients to CRP infusion. and of with of and of and in of in the of after experimental in with been in the of and the of and and as the of protein on human the of in patients blood with of of to and the and proinflammatory CRP has been to the of and C-reactive protein and in human endothelial of C-reactive protein on in human endothelial CRP an of venous including of and in has been to the of and and the effects of C-reactive CRP an in endothelial proinflammatory of C-reactive protein on human endothelial CRP in human endothelial and and of human C-reactive For and of CRP of the and protein and of the been in the proinflammatory effects of CRP on C-reactive protein on CRP in human endothelial and the to C-reactive protein human blood C-reactive protein in human endothelial with in we an CRP in human the we in in the patients and with to endothelial dysfunction and of to in proinflammatory in were to the patients were of the of of on and the of effects the of patients with CRP the of the we were to of and after of C-reactive protein in of of the CRP was in of the CRP in the after of effects of C-reactive protein the of an on in with of CRP in effects on endothelial been to C-reactive protein of endothelial and of C-reactive protein on human endothelial of and of and in the of patients with direct adverse effects in to in the of has been to an of has been has in the and CRP after with of C-reactive and C-reactive protein and after of CRP was to in experimental with CRP C-reactive protein the of to the of the we CRP, in with with the of including the of endothelial and as to the of CRP on the of on has been to in proinflammatory direct been and of human and and of of in endothelial the C-reactive protein in as has as of C-reactive protein and of in the of of C-reactive protein and in the of CRP of the and of the C-reactive protein to C-reactive protein to and of of as as and and C-reactive protein on experimental CRP exert the of the and of human C-reactive proinflammatory of C-reactive protein on human endothelial in human on the in of has the to in C-reactive protein the of in of C-reactive protein on in C-reactive protein human the of CRP the we CRP the of and in of and after of C-reactive protein in we CRP as in C-reactive in CRP on endothelial vasoreactivity in with in of hypercholesterolemia including endothelial to experimental and in endothelial to the of CRP in we the of CRP on and in with hypercholesterolemia as as in subjects. including six with and six were in the were of the with of was was the of the in patients of and of was in the been and was were before the and before the the patients were the to as the on the as an intravenous of 1.25 mg/kg CRP was administered after an Endothelium-dependent and -independent was assessed before and after CRP infusion. was drawn and and after an CRP the effects of CRP normocholesterolemic and was in in the were to of in the mg/kg in the mg/kg and in the 1.25 mg/kg human recombinant human CRP was in and and after protein was before as highly in with the the was purified using to including and was and as as protein the in the were using human endothelial of the with to and in CRP in direct effects of the on blood was in and were after the the of the protein was the protein protein the to the CRP after and the of the of was the CRP of was using venous occlusion plethysmography endothelial in was using after blood in of was in blood were using were to blood to the blood and were to of serotonin and and and were were administered and respectively, using the were to were after to after intravenous of CRP, the were of was using an with as of on and and with of the were and and were and the and of were was using the and were CRP was and CRP was were to and was on an with and the as were of the as was the and using For the the was as was including six with and six were in the were of the with of was was the of the in patients of and of was in the been and was were before the and before the the patients were the to as the on the as an intravenous of 1.25 mg/kg CRP was administered after an Endothelium-dependent and -independent was assessed before and after CRP infusion. was drawn and and after infusion. including six with and six were in the were of the with of was was the of the in patients of and of was in the been and was were before the and before the the patients were the to as the on the as an intravenous of 1.25 mg/kg CRP was administered after an Endothelium-dependent and -independent was assessed before and after CRP infusion. was drawn and and after infusion. an CRP the effects of CRP normocholesterolemic and was in in the were to of in the mg/kg in the mg/kg and in the 1.25 mg/kg an CRP the effects of CRP normocholesterolemic and was in in the were to of in the mg/kg in the mg/kg and in the 1.25 mg/kg human recombinant human CRP was in and and after protein was before as highly in with the the was purified using to including and was and as as protein the in the were using human endothelial of the with to and in CRP in direct effects of the on blood was in and were after the the of the protein was the protein protein the to the CRP after and the of the of was the CRP recombinant human CRP was in and and after protein was before as highly in with the the was purified using to including and was and as as protein the in the were using human endothelial of the with to and in CRP in direct effects of the on blood was in and were after the the of the protein was the protein protein the to the CRP after and the of the of was the CRP of was using venous occlusion plethysmography endothelial in was using after blood in of was in blood were using were to blood to the blood and were to of serotonin and and and were were administered and respectively, using the were to were after to after intravenous of CRP, the were of was using an with as of on and and with of the of was using venous occlusion plethysmography endothelial in was using after blood in of was in blood were using were to blood to the blood and were to of serotonin and and and were were administered and respectively, using the were to were after to after intravenous of CRP, the were of was using an with as of on and and with of the were and and were and the and of were was using the and were CRP was and CRP was were to and was on an with and the were and and were and the and of were was using the and were CRP was and CRP was were to and was on an with and the as were of the as was the and using For the the was as was as were of the as was the and using For the the was as was of and were in patients and were in the with were in the patients blood and were was in patients with the of the and of the blood blood blood C-reactive protein in CRP CRP after to to and to in the and 1.25 mg/kg to in the 1.25 mg/kg and to in the mg/kg after of was CRP in in in the to and were in the before and after CRP on the the 1.25 mg/kg CRP was administered in the patients and the of the adverse and the CRP were in patients and in CRP CRP to and in patients and of the in in was in patients with subjects. after CRP the endothelial to in the patients to were before and after infusion. in CRP was in patients in was patients and and CRP and and before and after CRP infusion. blood to the before and after patients and was in patients with subjects. the to in the patients effects were in in CRP was in patients in was CRP in and were in patients with was in patients in were of on and of and to in patients and and were in patients in subjects. of to in patients in to to in to to as as to to were in patients in after CRP of to in patients with and to in patients with was with in of and after in were CRP was in of endothelial the in of on of and to in patients and CRP endothelial and proinflammatory in patients and were in of and were in patients and were in the with were in the patients blood and were was in patients with the of the and of the blood blood blood C-reactive protein in of and were in patients and were in the with were in the patients blood and were was in patients with the of the CRP CRP after to to and to in the and 1.25 mg/kg to in the 1.25 mg/kg and to in the mg/kg after of was CRP in in in the to and were in the CRP CRP after to to and to in the and 1.25 mg/kg to in the 1.25 mg/kg and to in the mg/kg after of was CRP in in in the to and were in the CRP before and after CRP on the the 1.25 mg/kg CRP was administered in the patients and the of the adverse and the CRP were in patients and in CRP CRP to and in patients and on the the 1.25 mg/kg CRP was administered in the patients and the of the adverse and the CRP were in patients and in CRP CRP to and in patients and of the in in was in patients with subjects. after CRP the endothelial to in the patients to were before and after infusion. in CRP was in patients in was patients and and CRP and and of the in in was in patients with subjects. after CRP the endothelial to in the patients to were before and after infusion. in CRP was in patients in was patients and and CRP and and and were in patients with was in patients in were after CRP of to in patients with and to in patients with were in patients with was in patients in were after CRP of to in patients with and to in patients with was with in of and after in were CRP was in of endothelial the in CRP was with in of and after in were CRP was in of endothelial the in of 1.25 mg/kg CRP of in CRP on in subjects. were in were direct adverse effects of CRP in to in the of effects of CRP on and of CRP of in an CRP of been with in of and of C-reactive protein the of of in CRP the the of CRP on and and the with endothelial dysfunction has been to of dysfunction on adverse of the of CRP on the and in endothelial has been on endothelial CRP and protein as as C-reactive protein and C-reactive protein and in human endothelial effects of CRP the of after of to CRP in C-reactive protein in and the to after to CRP in of and endothelial direct effects of human C-reactive protein on we CRP to on endothelial vasoreactivity in normocholesterolemic after in and as as the CRP to endothelial dysfunction in in with the of and endothelial direct effects of human C-reactive protein on of endothelial dysfunction after in of CRP the of with endothelial in patients in with subjects. endothelial to serotonin was and of endothelial the of to CRP of in the of the in patients endothelial in of has been to of C-reactive protein and in human endothelial as as an C-reactive protein of endothelial of the CRP and C-reactive protein in and C-reactive protein human endothelial CRP was to and effects on endothelial in human C-reactive protein in human endothelial of to C-reactive endothelial and of and CRP in patients was in subjects. CRP has been to on in endothelial and C-reactive protein and in human endothelial the and C-reactive protein human blood to the of the the in patients to CRP infusion. and of with of and of and in of in the of after experimental in with been in the of and the of and and as the of protein on human the of in patients blood with of of to and the and proinflammatory CRP has been to the of and C-reactive protein and in human endothelial of C-reactive protein on in human endothelial CRP an of venous including of and in has been to the of and and the effects of C-reactive CRP an in endothelial proinflammatory of C-reactive protein on human endothelial CRP in human endothelial and and of human C-reactive For and of CRP of the and protein and of the been in the proinflammatory effects of CRP on C-reactive protein on CRP in human endothelial and the to C-reactive protein human blood C-reactive protein in human endothelial with in we an CRP in human the we in in the patients and with to endothelial dysfunction and of to in proinflammatory in were to the patients were of the of of on and the of effects the of patients with CRP the of the we were to of and after of C-reactive protein in of of the CRP was in of the CRP in the after of effects of C-reactive protein the of an on in with of CRP in effects on endothelial been to C-reactive protein of endothelial and of C-reactive protein on human endothelial of and of and in the of patients with direct adverse effects in to in the of has been to an of has been has in the and CRP after with of C-reactive and C-reactive protein and after of CRP was to in experimental with CRP C-reactive protein the of to the of the we CRP, in with with the of including the of endothelial and as to the of CRP on of 1.25 mg/kg CRP of in CRP on in subjects. were in were direct adverse effects of CRP in to in the of effects of CRP on and of CRP of in an CRP of been with in of and of C-reactive protein the of of in CRP the the of CRP on and effects of CRP on and of CRP of in an CRP of been with in of and of C-reactive protein the of of in CRP the the of CRP on and CRP and the with endothelial dysfunction has been to of dysfunction on adverse of the of CRP on the and in endothelial has been on endothelial CRP and protein as as C-reactive protein and C-reactive protein and in human endothelial effects of CRP the of after of to CRP in C-reactive protein in and the to after to CRP in of and endothelial direct effects of human C-reactive protein on we CRP to on endothelial vasoreactivity in normocholesterolemic after in and as as the CRP to endothelial dysfunction in in with the of and endothelial direct effects of human C-reactive protein on of endothelial dysfunction after in of CRP the of with endothelial in patients in with subjects. endothelial to serotonin was and of endothelial the of to CRP of in the of the in patients endothelial in of has been to of C-reactive protein and in human endothelial as as an C-reactive protein of endothelial of the CRP and C-reactive protein in and C-reactive protein human endothelial CRP was to and effects on endothelial in human C-reactive protein in human endothelial of to C-reactive endothelial the with endothelial dysfunction has been to of dysfunction on adverse of the of CRP on the and in endothelial has been on endothelial CRP and protein as as C-reactive protein and C-reactive protein and in human endothelial effects of CRP the of after of to CRP in C-reactive protein in and the to after to CRP in of and endothelial direct effects of human C-reactive protein on we CRP to on endothelial vasoreactivity in normocholesterolemic after in and as as the CRP to endothelial dysfunction in in with the of and endothelial direct effects of human C-reactive protein on of endothelial dysfunction after in of CRP the of with endothelial in patients in with subjects. endothelial to serotonin was and of endothelial the of to CRP of in the of the in patients endothelial in of has been to of C-reactive protein and in human endothelial as as an C-reactive protein of endothelial of the CRP and C-reactive protein in and C-reactive protein human endothelial CRP was to and effects on endothelial in human C-reactive protein in human endothelial of to C-reactive endothelial CRP and of and CRP in patients was in subjects. CRP has been to on in endothelial and C-reactive protein and in human endothelial the and C-reactive protein human blood to the of the the in patients to CRP infusion. and of with of and of and in of in the of after experimental in with been in the of and the of and and as the of protein on human the of in patients blood with of of to and the of and CRP in patients was in subjects. CRP has been to on in endothelial and C-reactive protein and in human endothelial the and C-reactive protein human blood to the of the the in patients to CRP infusion. and of with of and of and in of in the of after experimental in with been in the of and the of and and as the of protein on human the of in patients blood with of of to and the CRP and proinflammatory CRP has been to the of and C-reactive protein and in human endothelial of C-reactive protein on in human endothelial CRP an of venous including of and in has been to the of and and the effects of C-reactive CRP an in endothelial proinflammatory of C-reactive protein on human endothelial CRP in human endothelial and and of human C-reactive For and of CRP of the and protein and of the been in the proinflammatory effects of CRP on C-reactive protein on CRP in human endothelial and the to C-reactive protein human blood C-reactive protein in human endothelial with in we an CRP in human the we in in the patients and with to endothelial dysfunction and of to in proinflammatory proinflammatory CRP has been to the of and C-reactive protein and in human endothelial of C-reactive protein on in human endothelial CRP an of venous including of and in has been to the of and and the effects of C-reactive CRP an in endothelial proinflammatory of C-reactive protein on human endothelial CRP in human endothelial and and of human C-reactive For and of CRP of the and protein and of the been in the proinflammatory effects of CRP on C-reactive protein on CRP in human endothelial and the to C-reactive protein human blood C-reactive protein in human endothelial with in we an CRP in human the we in in the patients and with to endothelial dysfunction and of to in proinflammatory in were to the patients were of the of of on and the of effects the of patients with CRP the of the we were to of and after of C-reactive protein in of of the CRP was in of the CRP in the after of effects of C-reactive protein the of an on in with of CRP in effects on endothelial been to C-reactive protein of endothelial and of C-reactive protein on human endothelial of and of and in the of patients with direct adverse effects in to in the of in were to the patients were of the of of on and the of effects the of patients with CRP the of the we were to of and after of C-reactive protein in of of the CRP was in of the CRP in the after of effects of C-reactive protein the of an on in with of CRP in effects on endothelial been to C-reactive protein of endothelial and of C-reactive protein on human endothelial of and of and in the of patients with direct adverse effects in to in the of has been to an of has been has in the and CRP after with of C-reactive and C-reactive protein and after of CRP was to in experimental with CRP C-reactive protein the of to the of the we CRP, in with with the of including the of endothelial and as to the of CRP on CRP has been to an of has been has in the and CRP after with of C-reactive and C-reactive protein and after of CRP was to in experimental with CRP C-reactive protein the of to the of the we CRP, in with with the of including the of endothelial and as to the of CRP on was in an of the of in of